UNRESECTABLE LEIOMYOSARCOMA
Clinical trials for UNRESECTABLE LEIOMYOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE LEIOMYOSARCOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE LEIOMYOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo tested to halt aggressive sarcoma
Disease control OngoingThis study is testing whether combining two drugs, cabozantinib and temozolomide, can better control advanced soft tissue sarcomas that cannot be removed by surgery or have spread. The trial aims to see if this combination can stop the cancer from growing for longer and improve s…
Matched conditions: UNRESECTABLE LEIOMYOSARCOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New Three-Drug attack on tough sarcomas enters key test
Disease control OngoingThis study is testing if a three-drug combination works better than a two-drug immunotherapy approach to control advanced soft tissue sarcoma. It will involve about 66 adults with specific types of sarcoma that have spread or cannot be surgically removed. The goal is to see if ad…
Matched conditions: UNRESECTABLE LEIOMYOSARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute LAO • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC